La cadena de opciones muestra datos clave de las opciones de acciones de Cytek Biosciences a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Cytek Biosciences..

Cytek Biosciences (NASDAQ:CTKB) Bolsa, Cadena de Opciones

Cytek Biosciences

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Cytek Biosciences Inc

News

Health Care

Press Releases

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

General

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

Management

Mdxhealth Appoints Michael Holder to Board of Directors and  Announces Management Change

Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025

Earnings

Cytek Biosciences Reports Second Quarter 2025 Financial Results

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth

Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025

Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

CTKB

MDXH

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Codexis

CryoPort

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Evotec

Fortrea Holdings

Standard BioTools

Lifecore Biomedical

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Niagen Bioscience

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Personalis

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Sotera Health

Alpha Teknova

10x Genomics

Morgan Stanley

Goldman Sachs

Stephens & Co.

Piper Sandler

Comments

Cytek Biosciences

Cytek Biosciences (CTKB) Opciones

Cytek Biosciences (NASDAQ:CTKB) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL